News

Fueled by a unique blend of innovation, talent, and collaboration, Austin has built a reputation as a tech powerhouse, but ...
Tresidder said his Melbourne-based firm has “a real focus” on biotech and life sciences. He sketched some of the ways brokers ...
Chemical & Materials Engineering Assistant Professor Maryam Raeeszadeh-Sarmazdeh shares a few thoughts about her work and the ...
HBCUs are revolutionizing Black entrepreneurship through 3 major innovation programs that provide mentorship, funding and ...
At this year's South by Southwest (SXSW) conference in Austin, Texas, Future Today Strategy Group founder and CEO Amy Webb ...
The pharma will pay $800 million for the biotech, which was launched nearly two decades ago by Alnylam and Ionis to advance ...
The researchers now plan to incorporate their new tool into a drug development program, leading to early clinical trials.
The Center for a New American Security (CNAS) is pleased to welcome two new adjunct senior fellows: Liza Tobin, who joins ...
Learn more about Anbio Biotechnology's (NNNN) stock grades for Value and determine whether this Biotechnology stock meets your investment needs.
We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking ...
DNA hacking is no longer science fiction. A new study reveals major cybersecurity flaws in genetic sequencing technology.
Tharimmune, Inc., (NASDAQ:THAR) (”Tharimmune” or the “Company”) a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology, today announced ...